Skip to content

INGN

Inogen, Inc.

NASDAQ · Healthcare · Medical - Devices · US

$5.42
−0.55%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue354.3M348.7M335.7M315.7M377.2M
Cost of Revenue181.1M182.8M181.0M189.0M223.7M
Gross Profit173.2M165.9M154.7M126.7M153.5M
Operating Expenses
R&D Expense21.1M19.4M21.6M20.8M21.9M
SG&A Expense167.4M165.1M175.6M182.4M164.7M
General & Admin Expense69.4M67.4M72.6M75.3M43.9M
Selling & Marketing Expense98.0M97.7M103.1M107.1M120.8M
Other Expenses14.6M11.6M32.9M52.2M
Total Operating Expenses203.2M196.1M197.3M236.1M238.8M
Cost and Expenses384.2M378.9M378.2M425.0M462.5M
Operating Income (EBIT)(29.9M)(30.2M)(42.5M)(109.4M)(85.2M)
Non-Operating
Interest Income3.9M2.2M5.2M6.6M2.8M
Interest Expense
Net Interest Income3.9M2.2M5.2M6.6M2.8M
Other Non-Op Income/Expense4.6M6.8M6.0M7.0M2.0M
Non-Operating Income (excl Interest)(4.6M)(6.8M)(6.0M)(32.9M)(52.2M)
EBT (Pre-Tax Income)(25.3M)(23.4M)(36.5M)(102.3M)(83.3M)
Income Tax Expense(710.0K)(632.0K)(588.0K)105.0K504.0K
Bottom Line
Net Income(24.6M)(22.7M)(35.9M)(102.4M)(83.8M)
Earnings from Cont. Ops(24.6M)(22.7M)(35.9M)(102.4M)(83.8M)
Earnings from Discont. Ops
Bottom Line Net Income(24.6M)(22.7M)(35.9M)(102.4M)(83.8M)
Per Share
Basic EPS($0.90)($0.85)($1.52)($4.42)($3.67)
Diluted EPS($0.90)($0.85)($1.52)($4.42)($3.67)
Revenue Per Share$13.10$12.83$14.19$13.62$16.51
Shares
Basic Shares Outstanding27.0M27.2M23.7M23.2M22.9M
Diluted Shares Outstanding27.0M27.2M23.7M23.2M22.9M
Profitability Metrics
EBITDA(6.7M)(2.7M)(15.5M)(58.3M)(9.6M)
D&A18.6M20.7M21.0M18.2M23.5M
EBIT(25.3M)(23.4M)(36.5M)(76.5M)(33.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026